Compounds > threonine

threonine and Acute Lymphoid Leukemia

threonine has been researched along with Acute Lymphoid Leukemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
How, GF; Lim, LC; Müller, MC1
Copik, AJ; Johnson, BH; Kumar, R; Miller, AL; Thompson, EB; Wang, Y; Webb, MS1
Armstrong, BK; Baker, D; de Klerk, NH; Kees, UR; Milne, E; Thompson, JR; van Bockxmeer, F1
Akkari, Y; Cunningham, M; Fan, G; Malempati, S; Olson, S; Sears, RC; Tibbitts, D1
Housset, D; Jaskólski, M; Rao, JK; Swain, AL; Wlodawer, A1

Other Studies

5 other study(ies) available for threonine and Acute Lymphoid Leukemia

ArticleYear
Acquisition of the novel ABL kinase domain mutation T315L in a relapsed Philadelphia-positive acute lymphoblastic leukemia patient.
    Leukemia research, 2012, Volume: 36, Issue:1

    Topics: Amino Acid Substitution; Base Sequence; Catalytic Domain; Fusion Proteins, bcr-abl; Humans; Karyotype; Leucine; Male; Middle Aged; Mutation, Missense; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Threonine

2012
p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.
    Molecular endocrinology (Baltimore, Md.), 2005, Volume: 19, Issue:6

    Topics: Alanine; Animals; Apoptosis; Cell Line; Cell Line, Tumor; Cell Survival; Dexamethasone; DNA; Enzyme Activation; Flow Cytometry; Glucocorticoids; Humans; Immunohistochemistry; Kinetics; Lymphocytes; MAP Kinase Kinase 3; MAP Kinase Signaling System; Mice; Models, Biological; Mutation; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Propidium; Proto-Oncogene Proteins c-myc; Receptors, Glucocorticoid; RNA, Messenger; Serine; Signal Transduction; Threonine; Time Factors; Transcriptional Activation; Transfection

2005
Is there a folate-related gene-environment interaction in the etiology of childhood acute lymphoblastic leukemia?
    International journal of cancer, 2006, Jul-01, Volume: 119, Issue:1

    Topics: Alanine; Bone Marrow; Child; Child, Preschool; Cysteine; Dietary Supplements; DNA, Neoplasm; Female; Folic Acid; Genotype; Humans; Infant; Male; Methylenetetrahydrofolate Reductase (NADPH2); Mothers; Odds Ratio; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pregnancy; Threonine

2006
Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias.
    Leukemia, 2006, Volume: 20, Issue:9

    Topics: Amino Acid Sequence; Blotting, Western; Cell Line; Child; Enzyme Activation; Gene Amplification; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Immunoprecipitation; In Situ Hybridization, Fluorescence; Molecular Sequence Data; Phosphatidylinositol 3-Kinases; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins c-myc; Sequence Homology, Amino Acid; Serine; Threonine

2006
Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Feb-15, Volume: 90, Issue:4

    Topics: Amino Acid Sequence; Asparaginase; Binding Sites; Escherichia coli; Humans; Macromolecular Substances; Models, Molecular; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Conformation; Protein Structure, Secondary; Threonine; X-Ray Diffraction

1993